Why MUC16 mutations lead to a better prognosis: A study based on The Cancer Genome Atlas gastric cancer cohort

doi:10.12998/wjcc.v9.i17.4143

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5883)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series.

Item

Count

PDF

338

WORD

157

HTML

3239

Figures (1-7)

401

Sum=4135

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

424

Download

1324

Sum=1748

Jun 16, 2021 (publication date) through Jan 9, 2025

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Jun 16, 2021; 9(17): 4143-4158
Published online Jun 16, 2021. doi: 10.12998/wjcc.v9.i17.4143

Full Size Figure Download Figure

Figure 4 Prognosis and gene set enrichment analysis. A and B: Kaplan-Meier survival analysis for The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) cohorts, respectively; C and D: Overall survival time distribution in the TCGA cohort and GEO cohort; E and F: Distribution of risk scores in TCGA and GEO cohorts; G and H: Gene set enrichment analysis in the TCGA and GEO cohorts, respectively. The plots on the left are the TCGA cohort and the plots on the right are the GEO cohort. NPY1R: Neuropeptide Y receptor Y1.

Citation: Huang YJ, Cao ZF, Wang J, Yang J, Wei YJ, Tang YC, Cheng YX, Zhou J, Zhang ZX. Why MUC16 mutations lead to a better prognosis: A study based on The Cancer Genome Atlas gastric cancer cohort. World J Clin Cases 2021; 9(17): 4143-4158
URL: https://www.wjgnet.com/2307-8960/full/v9/i17/4143.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i17.4143